LEVICEPT

Updated 19 days ago
Private Limited Company
  • Active - 08190142 (CH)
  • Age: 11 years
  • ID: 30287749/101
Innovation House Discovery Park Ramsgate Road Sandwich Kent CT13 9ND
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 74909 - Other professional, scientific and technical activities n.e.c.
Levicept is a UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. LEVI-04 is currently in a phase II clinical trial in patients with osteoarthritis of the knee. LEVI-04 modulates the neurotrophin pathway, clinically proven to provide effective analgesia in a range of indications and is designed to minimise use-limiting side effects of anti-NGF antibodies, including rapid progression of osteoarthritis.
Also known as: Levicept Limited, LEVICEPT LTD
Registration numbers: 08190142 (CH)
Primary location: Kent United Kingdom
  • 0
  • 0
Interest Score
1
HIT Score
0.95
CEO
Eliot Forster
CSO
Simon Westbrook
Chairman
Kevin Johnson
Founder
Simon Westbrook
General
in..@levicept.com

UK Company Data

Company number
08190142		 Account category
SMALL		 Account ref. day
30		 Account ref. month
9
Accounts next due date
2024-06-30		 Accounts last made up date
2022-09-30		 Returns next due date
2016-09-20		 Returns last made up date
2015-08-23
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
levicept.com
Actual
www.levicept.com
IP
134.209.29.29
Status
OK
Category
Company
0 comments Add a comment